Mary Teeling
Assistant Professor, School Office - Medicine

Biography

I am a specialist pharmaceutical physician with extensive experience in the areas of pharmacology and pharmaceutical medicine. In addition to my role as Assistant Professor, in the School of Medicine, Trinity College Dublin, I also work in the National Medicines Information Centre (NMIC) as a part-time medical advisor. I worked in the national regulatory authority (Irish Medicines Board) for 12 years and served as its medical director from 1995-2000. I was a member of the European scientific committee (Committee for Human Medicinal Products) from 1994-2000 and was appointed to the role of vice-chairman in 1998 until 2000. In my role as medical advisor in the NMIC, I am the co-author of the NMIC publications Therapeutics Today and NMIC Bulletin, which provide updates on therapeutic topics to primary care physicians and other healthcare professionals. I was part of the education team that developed the higher specialist training (HST) programme in Pharmaceutical Medicine, in conjunction with the Royal College of Physicians in Ireland (RCPI). I am currently the National Specialty Director for Pharmaceutical Medicine and a member of the Irish Committee for Higher Medical Training (ICHMT) in RCPI.

Publications and Further Research Outputs

Peer-Reviewed Publications

Cooper JA, Moriarty F, Ryan C, Smith SM, Bennett K, Fahey T, Wallace E, Cahir C, Williams D, Teeling M, Hughes CM., Potentially inappropriate prescribing in two populations with differing socio-economic profiles: a cross-sectional database study using the PROMPT criteria., European Journal of Clinical Pharmacology, 72, (5), 2016, p583 - 591 Journal Article, 2016

O'Shea MP, Teeling M, Bennett K., Regional variation in medication-taking behaviour of new users of oral anti-hyperglycaemic therapy in Ireland, Irish Journal of Medical Science, 184, (2), 2015, p403 - 410 Journal Article, 2015

O'Shea MP, Teeling M, Bennett K., Comorbidity, health-related quality of life and self-care in type 2 diabetes: a cross-sectional study in an outpatient population., Irish Journal of Medical Science, 184, (3), 2015, p623 - 630 Journal Article, 2015

Cooper JA, Ryan C, Smith SM, Wallace E, Bennett K, Cahir C, Williams D, Teeling M, Fahey T, Hughes CM; (The PROMPT Steering Group) , The development of the PROMPT (PRescribing Optimally in Middle-aged People's Treatments) criteria., BMC Health Services Research, 14, 2014, p13 Journal Article, 2014

O'Shea MP, Teeling M, Bennett K., An observational study examining the effect of comorbidity on the rates of persistence and adherence to newly initiated oral anti-hyperglycaemic agents., Pharmacoepidemiology and Drug Safety, 12, 2013, p1336 - 1344 Journal Article, 2013

O'Shea M, Teeling M, Bennett K, The prevalence and ingredient cost of chronic comorbidity in the Irish elderly population with medication treated type 2 diabetes: A retrospective cross-sectional study using a national pharmacy claims database., BMC health services research, 13, 2013, p23 Journal Article, 2013 DOI TARA - Full Text

Cahir C, Fahey T, Teeling M, Teljeur C, Feely J, Bennett K, , Potentially inappropriate prescribing and cost outcomes for older people: a national population study, British Journal of Clinical Pharmacology, 69, 2010, p542 - 552 Journal Article, 2010

M. Teeling, H. O'Connor, J. Feely, K. Bennett, What therapies have replaced rofecoxib in Ireland ?, British Journal of Clinical Pharmacology, 64, (4), 2007, p536 - 541 Journal Article, 2007

C. Usher, M. Teeling, K. Bennett, J. Feely, Effect of clinical trial publicity on HRT prescribing in Ireland, European Journal of Clinical Pharmacology, 1, 2006, p4 Journal Article, 2006

M. Teeling, K. Bennett, J. Feely, What therapies have replaced Rofecoxib, Pharmacoepidemiology and Drug Safety, 15, 2006, S46 Journal Article, 2006

M. Savage, M. Teeling, K. Bennett, J. Feely, Adherence to clinical guidance in the prescribing of oral antithrombotic medication in patients with atrial fibrillation, Irish Journal of Medical Science, 175, (2), 2006, p46 - 49 Journal Article, 2006

M. Teeling, K. Bennett, H. O'Connor, J. Feely, How did the withdrawal of rofecoxib impact on prescribing of non-steroidal anti-inflammatory drugs ?, British Journal of Clinical Pharmacology, 61, 2006, pp637 - 638 Meeting Abstract, 2006

M. Teeling, J. Feely, Adverse drug reactions: reducing the risk in older people, Prescriber, 5, 2005, p12 - 19 Journal Article, 2005

K. Bennett, M. Teeling, J. Feely, Overprescribing antidepressants to children: pharmacoepidemiological study in, British Medical Journal, 331, 2005, p1451 - 1452 Journal Article, 2005

Teeling M, Bennett K, Feely J., The influence of guidelines on the use of statins: analysis of prescribing trends 1998-2002., British Journal of Clinical Pharmacology, 59, 2005, p227 - 232 Journal Article, 2005

M. Savage, M. Teeling, K. Bennett and J. Feely, Adherence to clinical guidance in the prescribing of anticoagulant medication in patients with atrial fibrillation, British Journal of Clinical Pharmacology, 59, 2005, 646 Meeting Abstract, 2005

C. Usher, M. Teeling, K. Bennett, B. McGowan, J. Feely, Usage of paracetamol-containing combination analgesics remains high in primary, British Journal of Clinical Pharmacology, 60, (6), 2005, p648 - 652 Journal Article, 2005

Teeling M, Bennett K, Feely J. , Have COX-2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs., British Journal of Clinical Pharmacology, 57, 2004, p337 - 343 Journal Article, 2004

M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ? , British Journal of Clinical Pharmacology, 55, 2003, 419 Meeting Abstract, 2003

Bennett K, Teeling M, Feely J., "Selective" switching from non-selective to selective non-steroidal anti-inflammatory drugs, Eur J Clin Pharmacol., 59, (8-9), 2003, p645 - 649 Journal Article, 2003

K. Bennett, M. Teeling and J. Feely, Selective switching from non-selective to selective non-steroidal anti-inflammatory drugs, European Journal of Clinical Pharmacology, 59, (38238), 2003, p645-9 Journal Article, 2003 URL

McGing P., Daly R., Teeling M., Kyne F., Carney D.N., Serum TPS (TPA) and CA125 as prognostic markers in ovarian cancer, Proc Nat. Meeting of Assoc. of Clin Biochem., 1994 Journal Article, 1994

Teeling M., Hayes Y., Fitzmaurice B., McGing P., Carney D.N., Carboplatin / Cyclophosphamide Combination Chemotherapy for advanced ovarian cancer, Seminars Oncol., 19, (1(Suppl. 2)1), 1992, p102 - 106 Journal Article, 1992

Teeling M., Carney D.N., Phase II study of carboplatin and cyclophosphamide combination chemotherapy for the treatment of advanced ovarian cancer, Eur. J of Gynaecol Oncol, 11, (3), 1990, p219 - 224 Journal Article, 1990

Carboplatin plus cyclophosphamide for epithelial ovarian cancer in, editor(s)P.A. Bunn Jr., R., Cannetta, R.F. Ozols, M. Rozencwieg , Carboplatin (JM8) Current perspectives and future directions, W.B. Saunders Company, 1990, [Carney D.N., Teeling M.] Book Chapter, 1990

McGing P.G., Teeling M., McCann A., Kyne F, Carney D.N., Non-MCK - a practical measure of creatinine kinase in cancer patients, Clin Chim Acta, 187, (3), 1990, p309 - 315 Journal Article, 1990

Splinter T.A.W., Carney D.N., Teeling M. Peake M.D., Kho GS, Oosterom R. and Cooper E.J., Neuron-Specific enolase can be used as the sole guide to treat small cell lung cancer patients, J. Cancer Res. Clin. Oncology, 115, (4), 1989, p400 - 401 Journal Article, 1989

Teeling M., McGing P., Johnston P., Carney D.N., Clinical Correlation of Tumor Endocrine Markers in Lung in cancer, Cancer Treat Res, 45, 1989, p137 - 149 Journal Article, 1989

Teeling M., Carney D., Casey B., Pratt I. and Ryan M.P., Comparison of the effects of cisplatin and carboplatin on magnesium status in cancer patients, Magnesium Research, 2, 1989, p101 - 101 Journal Article, 1989

Teeling M, McGing P, Carney DN, The prognostic value of post chemotherapy serum CA 125 in epithelial ovarian cancer, Ir. J. Med. Sci, 58, (3), 1989, p59 - 62 Journal Article, 1989

Splinter TA, Carney DN, Teeling M, Oosterom R., Levels of Neuron-specific enolase after chemotherapy do not predict a response in small cell lung cancer, J. Cancer Res Clin Oncol, 114, (6), 1988, p641 - 643 Journal Article, 1988

Carney D.N, Teeling M., Neuron-Specific Enolase: How useful as a Cancer Maker?, Eur. J. Cancer Clin. Oncol., 24, (5), 1988, p825 - 828 Journal Article, 1988

Biochemical Markers of lung cancer in, editor(s)S. Rosen, J. Mulshine, F. Cuttita, P.G. Abrams , Biology of lung cancer: Diagnosis and Treatment, Marcel Dekker Inc., 1988, [Teeling M. and Carney D.N.] Book Chapter, 1988

O'Neill H, Teeling M, Carney DN, Ennis JT., Abdominal computed tomography in patients with small cell lung cancer, Ir. J. Med Sci, 157, (11), 1988, p344 - 347 Journal Article, 1988

Teeling M., Carney D.N., Carboplatin and cyclophosphamide combination chemotherapy in advanced ovarian cancer, Proc. Amer Soc. Clin. Oncol., 6, 1987, p458 - 458 Journal Article, 1987

Burke, E, Teeling M, Carney D, Eustace P., The Retinotoxic Effects of Oncological Agents, Bull Soc. Belge Ophthalmol, 224, 1987, p77 - 79 Journal Article, 1987

Teeling M., Casey B., Pratt I., Ryan M.P. and Carney D.N., N-acetyl-B-glucosaminidase (B Nag) as an early predictor of renal tubular dysfunction in cisplatin nephrotoxicity, Proc. Am. Soc. Clin Oncol., 5, 1986, p204 - 204 Journal Article, 1986

Teeling M., Casey B., Carney D.N., Pratt I. and Ryan M.P., Differential nephrotoxicity of cisplatin and carboplatin, Clinical Science, 71, (suppl. 15), 1986, p76 - 76 Journal Article, 1986

Dervan P., Teeling M., Dempsey J., Drury M., Murphy J., O'Malley E. and O'Connell D., Lymphadenopathy due to fatal histiocytic proliferative disorder containing Michaelis-Gutmann Bodies, Cancer, 57, (7), 1986, p1337 - 1340 Journal Article, 1986

Teeling M., Conlon D., Pratt I., Carney D.N. and Ryan M.P., Prospective investigation of Cisplatin-induced nephrotoxicity including renal magnesium wasting in cancer patients, J. American College Nutrition, 5, 1985, p1489 - 1489 Journal Article, 1985

Robinson A.C.R., Teeling M. and Casey E.B., Hepatic function in ankylosing spondylitis, Annals of Rheumatic diseases, 42, (5), 1983, p550 - 552 Journal Article, 1983

Robinson A. and Teeling M., Angioneurotic oedema and urticaria induced by hyoscine butyl bromide, Post Graduate Medical Journal, 58, (679), 1982, p316 - 316 Journal Article, 1982

Robinson A., Dockery J., Teeling M., Peacock A. and Casey E., Gonococcal arthritis in pregnancy: A report of two cases, Irish Journal of Medical Science, 151, (10), 1982, p313 - 314 Journal Article, 1982

Non-Peer-Reviewed Publications

Pharmacovigilance and Risk Management in, editor(s)A C Cartwright, B R Matthews , International Pharmaceutical Product Registration, , United Kingdom, Informa Healthcare, 2009, [Informa Healthcare] Book Chapter, 2009

M. Teeling, J. Feely, Prevention of NSAID side effects, Clinical Focus (Forum), 5, (4), 2005, p4 - 6 Journal Article, 2005

M. Teeling, K. Bennett, J. Feely, Have COX 2 inhibitors influenced the co-prescription of anti-ulcer drugs with NSAIDs ?, British Journal of Clinical Pharmacology, 55, 2004, 419 Meeting Abstract, 2004

Teeling M., "Use of Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003 Report, 2003

Teeling M., "Use of Lofexidine and Naloxone in the management of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2003 Report, 2003

Teeling M., "Use of Buprenorphine as an intervention in the treatment of Opiate Dependence Syndrome" Report for the National Advisory Committee on Drugs (NACD), Dublin, Stationery Office, Government Publications, 2002 Report, 2002

Teeling M., Licensing of Vaccines, Forum, 17, (7), 2000, p39 - 41 Journal Article, 2000

Teeling M, The European Regulatory Perspective: Scientific Advice, Int J. Pharm Med, 13, 1999, p92 - 92 Journal Article, 1999

Teeling M, Immunisation: New developments in vaccines, Modern Medicine, 27, (10), 1997, p67 - 68 Journal Article, 1997

Teeling M., Initial Experiences with the New European Regulatory Procedures, J. Eur Soc Reg Affairs, 3, (3), 1996, p53 - 54 Journal Article, 1996

Research Expertise

Description

. Clinical Pharmacology . Pharmaceutical Medicine . Clinical Oncology . Pharmacoepidemiology

Keywords

MEDICAL EDUCATION; MEDICATION USE; Medicines

Recognition

Representations

National Specialty Director, Pharmaceutical Medicine, Royal College of Physicians of Ireland. 2013-

Vice chairman of the Committee for Proprietary Medicinal Products (CPMP, European Medicines Agency 1998-2000

EU member of the Steering Committee on International Conference on Harmonisation (ICH) 1999-2000

Former chairman of the Scientific Advice Working Party, European Medicines Agency 1998-2000

Former chairman of the CPMP ad hoc committee on anti-cancer agents 1997-2000

Awards and Honours

1999 Outstanding Service Award - Drug Information Association (DIA). 1999

Memberships

Royal Academy of Medicine in Ireland (fellow)

International Society of Pharmacoepidemiology

Association of Pharmaceutical Physicians of Ireland (APPI)

Royal College of Physicians of Ireland (Fellow)